The trial involving 348 samples (200 women with
ovarian cancer and 148 controls) found the test to have both high specificity (87%) and high sensitivity
(90%), with a high overall Receiver Operating Characteristic (ROC)-Area Under the Curve (AUC) score
for accuracy of 0.92. In addition, the test detected all subtypes and stages of ovarian cancer in the samples
with the performance of the test between early-stage and late stage ovarian cancer not statistically different
(p>0.5).
The BARD1 Ova
This will put them on the map for sure!
- Forums
- ASX - By Stock
- IIQ
- Ann: OVARIAN CANCER CLINICAL STUDY RESULTS
Ann: OVARIAN CANCER CLINICAL STUDY RESULTS, page-3
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
51.0¢ |
Change
0.010(2.00%) |
Mkt cap ! $46.00M |
Open | High | Low | Value | Volume |
50.0¢ | 52.0¢ | 50.0¢ | $54.39K | 108.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3780 | 50.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
51.5¢ | 10806 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3780 | 0.500 |
5 | 59026 | 0.480 |
1 | 2082 | 0.475 |
3 | 21000 | 0.470 |
1 | 12000 | 0.465 |
Price($) | Vol. | No. |
---|---|---|
0.515 | 10806 | 2 |
0.520 | 7232 | 1 |
0.530 | 10960 | 1 |
0.555 | 793 | 1 |
0.560 | 8555 | 3 |
Last trade - 15.44pm 01/05/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
BPH
BPH ENERGY LTD
David Breeze, MD & Executive Chairman
David Breeze
MD & Executive Chairman
SPONSORED BY The Market Online